Brian P. McKeon, EVP, CFO, and Treasurer of IDEXX Laboratories (IDXX), has demonstrated a clear selling bias in his recent insider transactions, with no open-market purchases recorded in the past year. Since February 2024, McKeon has executed nine sales totaling approximately $14.2 million, including a concentrated divestment on February 7, 2024, where he sold shares across multiple transactions ranging from $346,747 to $4.07 million. The largest single sale that day amounted to $4.07 million, followed by another at $3.24 million, indicating a significant reduction in his holdings. Smaller sales on February 14, 2024, and February 15, 2024, included dispositions of $614,934 and $99,952, respectively, with a subsequent sale of $252,938 on February 14, 2025.
McKeon’s trading history shows a long-term pattern of net selling, with total sales of $14.16 million outweighing his $3.4 million in buys over 25 reported transactions. The absence of recent purchases suggests he has not been accumulating shares despite his executive role. While some transactions, such as those marked "M" (derivative) or "A" (award), reflect equity compensation adjustments, the bulk of his activity consists of outright sales ("S" and "F" codes). This trend aligns with executives periodically liquidating holdings for diversification or liquidity, though the scale and timing—particularly the multi-million-dollar disposals in early 2024—warrant attention given his position overseeing IDEXX’s financial strategy.
AI-assisted summary